Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Makara Journal of Health Research
Islahudin, Farida
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Factors Associated with Postacute COVID-19 Syndrome Among Patients in Malaysia Ballasingam, Ahtheemathurra; Islahudin, Farida; Abdul Aziz, Siti Azdiah; Makmor-Bakry, Mohd
Makara Journal of Health Research Vol. 27, No. 3
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Post-acute COVID-19 is known to affect multiple organs. It is essential to determine factors that affect post-acute COVID-19 syndrome and medications needed by patients for optimized care. Methods: A prospective cohort study was conducted among patients recruited by stratified sampling from two COVID-19 hospitals in Malaysia. Patients were followed up for 6 months using a standard questionnaire to identify demographics, symptoms, medications taken, and factors associated with post-acute COVID-19 syndrome. Results: A total of 388 were successfully followed up. The most frequently reported symptom was respiratory symptoms (N = 168, 43.30%), of which cough (N = 134, 34.54%) was the most common. After 12 weeks of follow-up, respiratory syndrome (N = 56,14.43%) was frequently reported, of which cough (N = 41, 10.57%) was the most common. For respiratory syndrome, patients were commonly managed with diphenhydramine cough suppressants (N = 6, 1.55%, month 4) and metered dose inhaler (MDI) salbutamol (N = 7, 1.8%, month 4). The risk factors for post-acute COVID-19 syndrome were increased by 1.02 times (95% CI: 1.01, 1.04) with each advanced year of age and 2.87 times (95%CI: 1.51–5.48) in the presence of co-morbidities. Conclusions: Post-acute COVID-19 causes multiorgan involvement, and symptoms may remain for months, with patients taking various medications. Patients with risk factors should be monitored closely for post-acute COVID-19 symptoms.
Barriers and Facilitators of Pharmacists’ Roles During the Pandemic in Malaysia Palani Velu, Thanushiri; Islahudin, Farida; Chong, Wei Wen
Makara Journal of Health Research Vol. 28, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: The coronavirus disease 2019 (COVID-19) left a devastating impact on healthcare systems worldwide. The crisis initially emerged as a supply disruption issue but eventually evolved into a myriad of additional challenges, which were attributed mainly to the extensive scale of the pandemic. This study aimed to explore the barriers to the role of hospital pharmacists and related facilitators encountered during the COVID-19 pandemic. Methods: Pharmacists in Malaysia participated in a cross-sectional online questionnaire-based survey. The participants were recruited using convenient sampling. Cronbach alpha of the questionnaire was analyzed. Results: The study successfully enrolled 367 pharmacists. The major barrier in terms of knowledge and skills was the difficulty in investigating the trend and usage pattern of COVID-19 medicines (N = 183; 49.9%). A global shortage of medicines (N = 314; 85.6%) occupied the highest barrier in the supply chain. The clinical barriers cited by most of the respondents comprised conducting clinical trials in the search for effective treatments (N = 282; 76.8%), and the largest departmental barrier was the difficulty of predicting usage based on previous data (N = 262; 71.4%). Almost all respondents agreed that a course or module on COVID-19 treatments (N = 354; 96.5%) served as a facilitator, enhancing their awareness and preparedness to respond to the pandemic. Conclusions: The empowerment of pharmacists with the crucial resources, skills, and support that will enable them to effectively fulfill their roles and responsibilities can be instrumental in the transformation of our approach to addressing future pandemics.
Co-Authors Abdul Aziz, Siti Azdiah Ballasingam, Ahtheemathurra Chong, Wei Wen Makmor-Bakry, Mohd Palani Velu, Thanushiri